PLUR

Pluri Inc.

Healthcare · Biotechnology

$85.01 sample

-0.59 (-0.69%) 1D

Market cap

$162.4B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$85.01 +4.08% 3M daily closessample

85.6077.13

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: General Counsel
Oct 02INSInsider sell: 10% owner
Sep 24INSInsider sell: Director
Sep 18INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: Chief Financial Officer
Sep 03INSInsider buy: 10% owner
Aug 25INSInsider sell: Chief Executive Officer
Aug 20INSInsider sell: EVP, Operations

Sign up to see the real PLUR record →

Company facts

SEC EDGAR registration

Name: Pluri Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -12sample, -100 to +100
Reporting currency: USD

Who is positioning in PLUR

sample

Insiders: 9 insider transactions over 90 days, net selling, $73.8M
Congress: 3 members traded over 90 days
Institutions · 13F: 30 funds hold $2.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.6B +16.3% y/y

Q4 2024Q3 2026

Inventory$2.6B +6.1% y/y

Q4 2024Q3 2026

Accounts receivable$2.1B +9.5% y/y

Q4 2024Q3 2026

Total debt$5.5B +15.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $66.1B +5.7% 3M
Sample peer B: $115.0B +2.0% 3M
Sample peer C: $20.9B -9.9% 3M
Sample peer D: $118.0B +3.4% 3M
Sample peer E: $150.7B -9.6% 3M